Novartis announce European Commission approval of Odomzo (formerly LDE225) for treatment of adults with locally invasive BCCs. For further information visit the following link. gorlingroup.org/jupgrade/in...
Novartis announce European Commission approval of Odomzo (formerly LDE225) for treatment of adults with locally invasive BCCs. For further information visit the following link. gorlingroup.org/jupgrade/in...